Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

  1. Guigay, J.
  2. Aupérin, A.
  3. Fayette, J.
  4. Saada-Bouzid, E.
  5. Lafond, C.
  6. Taberna, M.
  7. Geoffrois, L.
  8. Martin, L.
  9. Capitain, O.
  10. Cupissol, D.
  11. Castanie, H.
  12. Vansteene, D.
  13. Schafhausen, P.
  14. Johnson, A.
  15. Even, C.
  16. Sire, C.
  17. Duplomb, S.
  18. Evrard, C.
  19. Delord, J.-P.
  20. Laguerre, B.
  21. Zanetta, S.
  22. Chevassus-Clément, C.
  23. Fraslin, A.
  24. Louat, F.
  25. Sinigaglia, L.
  26. Keilholz, U.
  27. Bourhis, J.
  28. Mesia, R.
  29. BABA-HAMED, N.
  30. BABIN, E.
  31. BERA, G.
  32. BETRIAN-LAGARDE, S.
  33. BLOT, E.
  34. BOMPAS, E.
  35. BOREL, C.
  36. BOUCHEKOUA, M.
  37. BOZEC LE MOAL, L.
  38. BRUYAS, A.
  39. CALAIS, G.
  40. CARPIUC, I.
  41. CHAPET, S.
  42. CHATELLIER, T.
  43. CHAUFFERT, B.
  44. CHELI, S.
  45. CLATOT, F.
  46. COJOCARASU, O.
  47. CORNELLY, A.
  48. COUTTE, A.
  49. DALLOZ, P.
  50. DARLOY, F.
  51. DELHOMMEAU, M.
  52. DE RAUCOURT, D.
  53. DEBELLEIX, C.
  54. DEBOURDEAU, P.
  55. DILLIES-LEGRAIN, A.F.
  56. DO, P.
  57. DUBOS-ARVIS, C.
  58. DUCOULOMBIER, A.
  59. EL KOURI, C.
  60. FALKOWSKI, S.
  61. FERRAND, F.-R.
  62. GATINEAU, M.
  63. GERVAIS, R.
  64. GRAS, L.
  65. GUILLET, P.
  66. HASBINI, A.
  67. HENAULT, S.
  68. HERRERA GOMEZ, R.G.
  69. HUGUET, F.
  70. KAMINSKY, M.C.
  71. LAGRANGE, A.
  72. LAVAU-DENES, S.
  73. LE CAER, H.
  74. LE FOLL, C.
  75. LEFEBVRE, G.
  76. LINOT, B.
  77. LOPEZ, Q.
  78. LORTHOLARY, A.
  79. MATIAS, M.
  80. MAYACHE-BADIS, L.
  81. MINNE, F.
  82. MOLLON, D.
  83. NEIDHARDT, E.M.
  84. PAVILLET, J.
  85. PEYRADE, F.
  86. POINTREAU, Y.
  87. RAMEE, J.-F.
  88. RAUCHE, C.
  89. RICHARD, S.
  90. RIZZO, C.
  91. ROLLAND, F.
  92. SCHLURMANN, F.
  93. STEFANI, L.
  94. TASSY, L.
  95. TAZI, Y.
  96. THERY, J.-C.
  97. TORTI EL ZEIN, F.
  98. TOULLEC, C.
  99. TOURANI, J.-M.
  100. TOUSSAINT, P.
  101. VANBOCKSTAEL, J.
  102. VAULEON, E.
  103. VIRET, F.
  104. WALER, S.
  105. ATZPODIEN, J.
  106. BEHRENS, C.
  107. BUSCH, C.J.
  108. DIETZ, A.
  109. FELDMANN, G.
  110. FIETKAU, R.
  111. GRANIZKA, T.
  112. GREWE, J.
  113. GUNTINAS-LICHINUS, O.
  114. HADLER-MIKESCH, K.
  115. HAHN, D.
  116. INHESTERN, J.
  117. KELLNER, K.
  118. KLINGHAMMER, K.
  119. KRONENBERGER, R.
  120. LUEDTKE-HECKENKAMP, K.
  121. OCHSENREITHER, S.
  122. OTREMBA, B.
  123. PEUKER, C.A.
  124. PIRLICH, M.
  125. ROTHMANN, F.
  126. TOMETTEN, M.
  127. WOHLFARTH, S.
  128. ZEBRALLA, V.
  129. ZIPFEL, M.
  130. ADANSA KLEIN, J.C.
  131. ARRAZUBI, V.
  132. CABALLERO DAROQUI, J.
  133. CASTELO, B.
  134. CIRAUQUI CIRAUQUI, B.
  135. CRUZ HERNANDEZ, J.J.
  136. GALLEGO, O.
  137. IGLESIAS DOCAMPO, L.C.
  138. LOPEZ POUSA, A.
  139. MARTINEZ DEL PRADO, M.
  140. MARTINEZ-TRUFERO, J.
  141. PASTOR BORGONON, M.
  142. PEREZ RUIZ, E.
  143. QUIROGA GARCIA, V.
  144. RUBIO CASADEVALL, J.
  145. VAZQUEZ FERNANDEZ, S.
  146. Show all authors +
Journal:
The Lancet Oncology

ISSN: 1474-5488 1470-2045

Year of publication: 2021

Volume: 22

Issue: 4

Pages: 463-475

Type: Article

DOI: 10.1016/S1470-2045(20)30755-5 GOOGLE SCHOLAR